|
Feb 10
|
Top 11 CRISPR Stocks To Invest In
|
|
Feb 7
|
Cathie Wood Is Selling This Stock: Should You?
|
|
Jan 13
|
BIIB, ZTS, EXAS: Which “Strong Buy” Healthcare Stock is Best?
|
|
Jan 3
|
Moderna (MRNA) Moves 13.1% Higher: Will This Strength Last?
|
|
Jan 2
|
Exact Sciences to participate in J.P. Morgan Healthcare Conference
|
|
Dec 21
|
Exact Sciences' (EXAS) Solid Cologuard Sales, Innovation Aid
|
|
Dec 17
|
1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark Invest
|
|
Dec 14
|
Ark Invest Stock Portfolio: 16 Biggest Positions
|
|
Dec 13
|
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
|
|
Dec 7
|
Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings
|
|
Dec 4
|
Exact Sciences (EXAS) Up 35.4% YTD: Will the Rally Continue?
|
|
Dec 1
|
Why Is Exact Sciences (EXAS) Up 2.5% Since Last Earnings Report?
|
|
Dec 1
|
Exact Sciences Corporation (EXAS) Shares Pulled Back in Q3
|
|
Nov 30
|
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
|
|
Nov 29
|
If You Invested $1000 in Exact Sciences a Decade Ago, This is How Much It'd Be Worth Now
|
|
Nov 28
|
Investing in Exact Sciences (NASDAQ:EXAS) a year ago would have delivered you a 59% gain
|
|
Nov 6
|
Exact Sciences (EXAS) Just Overtook the 20-Day Moving Average
|
|
Nov 2
|
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
Exact Sciences, A Cathie Wood Holding, Comes In Hot With Double-Digit Sales Growth
|
|
Sep 12
|
Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
|